Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 326

Results For "CRE"

4423 News Found

Moderna announces advancements in mRNA platform science for application across multiple diseases
Biotech | May 17, 2022

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery


Takeda launches Adynovate for Hemophilia patients in India
News | May 16, 2022

Takeda launches Adynovate for Hemophilia patients in India

Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes


Biological E. reduces Corbevax price to Rs.250 a dose
News | May 16, 2022

Biological E. reduces Corbevax price to Rs.250 a dose

The move comes a few weeks after receiving the EUA for children between the ages of 5 and 12


New report highlights lack of access to assistive technology
Healthcare | May 16, 2022

New report highlights lack of access to assistive technology

WHO and UNICEF call on governments, industry, donors and civil society to fund and prioritize access to assistive products


Merck KGaA first quarter earnings grows on higher volumes, margins
News | May 15, 2022

Merck KGaA first quarter earnings grows on higher volumes, margins

Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter


Sarclisa (isatuximab) combination provides unprecedented median progression-free survival
Biotech | May 15, 2022

Sarclisa (isatuximab) combination provides unprecedented median progression-free survival

The median progression free survival, increased from 19.2 months to 35.7 months when Sarclisa was added to carfilzomib and dexamethasone


Zydus launches Bemdac to treat LDL-Cholesterol
Drug Approval | May 14, 2022

Zydus launches Bemdac to treat LDL-Cholesterol

It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins


WHO and MPP announce agreement with NIH for Covid-19 health technologies
Public Health | May 13, 2022

WHO and MPP announce agreement with NIH for Covid-19 health technologies

The licences will allow manufacturers from around the world to work with MPP and C-TAP to make these technologies accessible to people living in low- and middle-income countries


TwistPak: Mixing platform for swine vaccines brings convenience and flexibility
Biotech | May 13, 2022

TwistPak: Mixing platform for swine vaccines brings convenience and flexibility

Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being